West Chester, Pennsylvania (June 1, 2020) – The Brooks Group today announced an executive leadership transition: effective June 1, 2020, long-time President, Dan Brooks will become Managing Partner of The Brooks Group.
With that move, current Brooks Group, Sr. Partner Ryan Evans will be promoted, as the company’s new President. Today’s announcement represents the successful culmination of the board’s long-range leadership succession planning process. Since joining The Brooks Group in 2010, Ryan has been a key member of the team and has proven himself as a strong leader with extensive industry experience. Importantly, with the experience he has gained in the various roles he has held, Ryan is intimately familiar with Brooks business operations, evolving products, healthcare market landscape and customers.
Ryan has been responsible for overseeing all of Brooks business strategic advisory services, market research, and training with pharmaceutical companies and payers to enable them to position their value proposition in the era of Quadruple Aim.
“Ryan has been a consistent top performer since joining the Company ten years ago. His vision & strategy led to the hiring of a Chief Learning Officer & staff in 2019. With the advent of Covid-19, this strategy seems prescient and has positioned the Company well for the transformation now occurring. He is the ideal person to lead and prosper the Company into this rapidly evolving virtual environment and I’m proud to announce his promotion to President.”
Ryan said, “I am excited for the opportunity to lead The Brooks Group forward as its next president. We have a talented team, and I am honored to lead this team as we build on our momentum as an industry leader. Importantly, I want to thank Dan for his tremendous leadership, as well as his mentorship and friendship over the years. I look forward to transitioning with Dan, and I am appreciative of the opportunity to continue to benefit from his experience.”
Prior to joining The Brooks Group, Ryan held a variety of positions of increasing responsibility in sales, operations, training and general management during a 15-year career at Wyeth Pharmaceuticals.